These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2500869)
1. Purification and structural characterization of recombinant rat gamma-interferon from Escherichia coli. Lai CY; Dharm E; Fujii Y Anal Biochem; 1989 Feb; 176(2):326-9. PubMed ID: 2500869 [TBL] [Abstract][Full Text] [Related]
2. Refolding and single-step purification of porcine interferon-gamma from Escherichia coli inclusion bodies. Conditions for reconstitution of dimeric IFN-gamma. Vandenbroeck K; Martens E; D'Andrea S; Billiau A Eur J Biochem; 1993 Jul; 215(2):481-6. PubMed ID: 8344315 [TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of recombinant murine immune interferon. Nagata K; Kikuchi N; Ohara O; Teraoka H; Yoshida N; Kawade Y FEBS Lett; 1986 Sep; 205(2):200-4. PubMed ID: 3091401 [TBL] [Abstract][Full Text] [Related]
4. Production, purification and characterization of recombinant human interferon gamma. Zhang Z; Tong KT; Belew M; Pettersson T; Janson JC J Chromatogr; 1992 Jun; 604(1):143-55. PubMed ID: 1639923 [TBL] [Abstract][Full Text] [Related]
5. Differential purification by immunoaffinity chromatography of two carboxy-terminal portion-deleted derivatives of recombinant human interferon-gamma from Escherichia coli. Honda S; Asano T; Kajio T; Nakagawa S; Ikeyama S; Ichimori Y; Sugino H; Nara K; Kakinuma A; Kung HF J Interferon Res; 1987 Apr; 7(2):145-54. PubMed ID: 3112244 [TBL] [Abstract][Full Text] [Related]
6. Escherichia coli-derived human interferon-gamma with Cys-Tyr-Cys at the N-terminus is partially N alpha-acylated. Honda S; Asano T; Kajio T; Nishimura O Arch Biochem Biophys; 1989 Mar; 269(2):612-22. PubMed ID: 2493219 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of E. coli protein impurities in recombinant human interferon-gamma. Chen AB; Championsmith AA; Blanchard J; Gorrell J; Niepelt BA; Federici MM; Formento J; Sinicropi DV Appl Biochem Biotechnol; 1992 Aug; 36(2):137-52. PubMed ID: 1444359 [TBL] [Abstract][Full Text] [Related]
8. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution. Petrov S; Nacheva G; Ivanov I Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329 [TBL] [Abstract][Full Text] [Related]
9. Rapid purification of recombinant human tumor necrosis factor beta. Loh KC; Yao ZJ; Yap MG; Chung MC Protein Expr Purif; 1994 Feb; 5(1):70-5. PubMed ID: 8167476 [TBL] [Abstract][Full Text] [Related]
10. Acid unfolding and self-association of recombinant Escherichia coli derived human interferon gamma. Arakawa T; Hsu YR; Yphantis DA Biochemistry; 1987 Aug; 26(17):5428-32. PubMed ID: 3118946 [TBL] [Abstract][Full Text] [Related]
11. Binding of unglycosylated and glycosylated human recombinant interferon-gamma to cellular receptors. Littman SJ; Devos R; Baglioni C J Interferon Res; 1985; 5(3):471-6. PubMed ID: 2932505 [TBL] [Abstract][Full Text] [Related]
12. Purification and properties of a recombinant DNA-derived ovine growth hormone analogue (oGH1) expressed in Escherichia coli. Wallis OC; Wallis M J Mol Endocrinol; 1990 Feb; 4(1):61-9. PubMed ID: 2182044 [TBL] [Abstract][Full Text] [Related]
13. A simple and efficient method for the purification of human gamma interferon. Braude IA Prep Biochem; 1983; 13(3):177-90. PubMed ID: 6415649 [TBL] [Abstract][Full Text] [Related]
14. Purification of human gamma-interferon to essential homogeneity and its biochemical characterization. Braude IA Biochemistry; 1984 Nov; 23(23):5603-9. PubMed ID: 6439244 [TBL] [Abstract][Full Text] [Related]
16. Role of polycationic C-terminal portion in the structure and activity of recombinant human interferon-gamma. Arakawa T; Hsu YR; Parker CG; Lai PH J Biol Chem; 1986 Jun; 261(18):8534-9. PubMed ID: 3087976 [TBL] [Abstract][Full Text] [Related]
17. Determination of the complete amino acid sequence of recombinant human gamma-interferon produced in Escherichia coli. Yamazaki S; Shimazu T; Kimura S; Shimizu H J Interferon Res; 1986 Aug; 6(4):331-6. PubMed ID: 3095440 [TBL] [Abstract][Full Text] [Related]
18. Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli. Chen H; Li N; Xie Y; Jiang H; Yang X; Cagliero C; Shi S; Zhu C; Luo H; Chen J; Zhang L; Zhao M; Feng L; Lu H; Zhu J Appl Microbiol Biotechnol; 2017 Jul; 101(13):5267-5278. PubMed ID: 28391504 [TBL] [Abstract][Full Text] [Related]
19. Production of aggregation prone human interferon gamma and its mutant in highly soluble and biologically active form by SUMO fusion technology. Tileva M; Krachmarova E; Ivanov I; Maskos K; Nacheva G Protein Expr Purif; 2016 Jan; 117():26-34. PubMed ID: 26407523 [TBL] [Abstract][Full Text] [Related]
20. Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type. Slodowski O; Böhm J; Schöne B; Otto B Eur J Biochem; 1991 Dec; 202(3):1133-40. PubMed ID: 1662603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]